Pigmentary Disorders; Vitiligo and Melasma in Context of South Asian Countries: A Psychosocio-Cosmetic Challenge

  title={Pigmentary Disorders; Vitiligo and Melasma in Context of South Asian Countries: A Psychosocio-Cosmetic Challenge},
  author={Anil Kumar Jha and Subekcha Karki},
Vitiligo and melasma are acquired pigmentary disorder of the skin and also the leading cause for dermatologist consultation in South Asian countries like Nepal. Vitiligo vulgaris and melasma are common examples for depigmentary and hyperpigmentary conditions respectively. There are multiple proven medical, surgical and combined modalities of managing them but the challenge in our part of the world with majority of Fitzpatrick skin types III-V is; it remains a psychosocial-cosmetic disease. 
Comparative Study Of Efficacy and Safety of Topical Active Fragment of Basic Fibroblast Growth Factor (B FGF) 0.1% Solution V/S Betamethasone Valerate 0.1% Ointment in the Treatment of Vitiligo Patients
Topical (b FGF) was found to be more efficacious, safe and tolerable without any major side effects than topical (BV) 0.1% ointment in patients with clinically diagnosed vitiligo.
Anti-Inflammatory Activity of Calendula officinalis L. Flower Extract
The use of calendula for its lenitive properties’ dates to the XII century. This plant contains several bioactive compounds, including terpenoids, terpenes, carotenoids, flavonoids and


Remedial cosmetic cover creams help conceal the blemish of vitiligo at least temporarily by incorporating a high concentration of pigment into water–free or anhydrous foundations to give a color that matches the patient’s skin, thereby concealing Vitiligo patches.
Melasma update
The pathogenetic factors involved in melasma are reviewed, including genetic predisposition, ultraviolet radiation, hormonal factors, and drugs, and the newer treatment options available and their efficacy are described.
Vitiligo: A review of the published work
This article reviews vitiligo as a whole, including epidemiology, pathogenesis and etiology, histopathology, clinical manifestations, classification, clinical variants, diagnosis and differential diagnoses, specific investigation, treatment, prognosis, psychosocial view and its association with other disorders.
Melasma: Treatment with 10% tretinoin peeling mask
Melasma is one of the most frequently acquired hyperpigmentation disorders clinically characterized by symmetrical brown patches on sun exposed areas and necessitates consideration of many therapies, including tretinoin to obtain an amelioration of this important skin condition.
Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation
Khellin has phototherapeutic properties that are similar to those of the psoralens, but with substantially lower phototoxic effects and DNA mutation effects and its penetration into the hair follicles is enhanced by encapsulating it into liposomes.
Melasma: histopathological characteristics in 56 Korean patients
Melasma is a common acquired symmetrical hypermelanosis characterized by irregular light to dark brown macules and patches on sun‐exposed areas of the skin that is not fully understood.
Guidelines for the management of vitiligo: the European Dermatology Forum consensus
This guideline for the treatment of segmental and nonsegmental vitiligo has been developed by the members of the Vitiligo European Task Force and other colleagues and summarizes evidence‐based and expert‐based recommendations (S1 level).
Efficacy of topical calcineurin inhibitors in vitiligo
Double blind studies show that pimecrolimus 1% cream combined with narrow band UVB is superior to placebo, especially for facial lesions, and additional studies would further clarify the role of topical calcineurin inhibitors in vitiligo.
Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial
Rucinol (4‐n‐butylresorcinol) has been shown to inhibit the activity of both tyrosinase and TRP‐1, which catalyses the oxidation of the melanogenetic intermediate 5,6‐dihydroxyindole‐2‐carbolylic acid.
Treatment of Melasma With Oral Administration of Tranexamic Acid
Oral administration of tranexamic acid (TA) is an effective and safe therapy for the treatment of melasma and is graded into four levels: excellent, good, fair, and poor.